We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003453
Recruitment Status : Terminated (Slow enrollment)
First Posted : January 27, 2003
Last Update Posted : September 29, 2017
Information provided by (Responsible Party):
Burzynski Research Institute

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : July 5, 2011
  Study Completion Date : July 5, 2011

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 11, 2018